Li_2022_Drug.Des.Devel.Ther_16_3557

Reference

Title : Semaglutide May Alleviate Hepatic Steatosis in T2DM Combined with NFALD Mice via miR-5120\/ABHD6 - Li_2022_Drug.Des.Devel.Ther_16_3557
Author(s) : Li R , Ye Z , She D , Fang P , Zong G , Hu K , Kong D , Xu W , Li L , Zhou Y , Zhang K , Xue Y
Ref : Drug Des Devel Ther , 16 :3557 , 2022
Abstract : Li_2022_Drug.Des.Devel.Ther_16_3557
ESTHER : Li_2022_Drug.Des.Devel.Ther_16_3557
PubMedSearch : Li_2022_Drug.Des.Devel.Ther_16_3557
PubMedID: 36238196

Related information

Citations formats

Li R, Ye Z, She D, Fang P, Zong G, Hu K, Kong D, Xu W, Li L, Zhou Y, Zhang K, Xue Y (2022)
Semaglutide May Alleviate Hepatic Steatosis in T2DM Combined with NFALD Mice via miR-5120\/ABHD6
Drug Des Devel Ther 16 :3557

Li R, Ye Z, She D, Fang P, Zong G, Hu K, Kong D, Xu W, Li L, Zhou Y, Zhang K, Xue Y (2022)
Drug Des Devel Ther 16 :3557